South Korea Biologics Market Report by Source (Microbial, Mammalian, and Others), Product (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi and Molecular Therapy, and Others), Disease (Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, and Others), Manufacturing (Outsourced, In-House), and Region 2024-2032

South Korea Biologics Market Report by Source (Microbial, Mammalian, and Others), Product (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi and Molecular Therapy, and Others), Disease (Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, and Others), Manufacturing (Outsourced, In-House), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112025A20264

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   South Korea Biologics Market - Introduction

    4.1    Overview
    4.2    Market Dynamics
    4.3    Industry Trends
    4.4    Competitive Intelligence
5   South Korea Biologics Market Landscape
    5.1    Historical and Current Market Trends (2018-2023)
    5.2    Market Forecast (​2024-2032)
6   South Korea Biologics Market - Breakup by Source
    6.1    Microbial
        6.1.1 Overview
        6.1.2 Historical and Current Market Trends (2018-2023)
        6.1.3 Market Forecast (​2024-2032)
    6.2    Mammalian
        6.2.1 Overview
        6.2.2 Historical and Current Market Trends (2018-2023)
        6.2.3 Market Forecast (​2024-2032)
    6.3    Others
        6.3.1 Historical and Current Market Trends (2018-2023)
        6.3.2 Market Forecast (​2024-2032)
7   South Korea Biologics Market - Breakup by Product
    7.1    Monoclonal Antibodies
        7.1.1 Overview
        7.1.2 Historical and Current Market Trends (2018-2023)
        7.1.3 Market Forecast (​2024-2032)
    7.2    Vaccines
        7.2.1 Overview
        7.2.2 Historical and Current Market Trends (2018-2023)
        7.2.3 Market Forecast (​2024-2032)
    7.3    Recombinant Proteins
        7.3.1 Overview
        7.3.2 Historical and Current Market Trends (2018-2023)
        7.3.3 Market Forecast (​2024-2032)
    7.4    Antisense, RNAi and Molecular Therapy
        7.4.1 Overview
        7.4.2 Historical and Current Market Trends (2018-2023)
        7.4.3 Market Forecast (​2024-2032)
    7.5    Others
        7.5.1 Historical and Current Market Trends (2018-2023)
        7.5.2 Market Forecast (​2024-2032)
8   South Korea Biologics Market - Breakup by Disease
    8.1    Oncology
        8.1.1 Overview
        8.1.2 Historical and Current Market Trends (2018-2023)
        8.1.3 Market Forecast (​2024-2032)
    8.2    Immunological Disorders
        8.2.1 Overview
        8.2.2 Historical and Current Market Trends (2018-2023)
        8.2.3 Market Forecast (​2024-2032)
    8.3    Cardiovascular Disorders
        8.3.1 Overview
        8.3.2 Historical and Current Market Trends (2018-2023)
        8.3.3 Market Forecast (​2024-2032)
    8.4    Hematological Disorders
        8.4.1 Overview
        8.4.2 Historical and Current Market Trends (2018-2023)
        8.4.3 Market Forecast (​2024-2032)
    8.5    Others
        8.5.1 Historical and Current Market Trends (2018-2023)
        8.5.2 Market Forecast (​2024-2032)
9   South Korea Biologics Market - Breakup by Manufacturing
    9.1    Outsourced
        9.1.1 Overview
        9.1.2 Historical and Current Market Trends (2018-2023)
        9.1.3 Market Forecast (​2024-2032)
    9.2    In-House
        9.2.1 Overview
        9.2.2 Historical and Current Market Trends (2018-2023)
        9.2.3 Market Forecast (​2024-2032)
10  South Korea Biologics Market – Breakup by Region 
    10.1    Seoul Capital Area
        10.1.1 Overview
        10.1.2 Historical and Current Market Trends (2018-2023)
        10.1.3 Market Breakup by Source
        10.1.4 Market Breakup by Product
        10.1.5 Market Breakup by Disease
        10.1.6 Market Breakup by Manufacturing
        10.1.7 Key Players
        10.1.8 Market Forecast (​2024-2032)
    10.2    Yeongnam (Southeastern Region)
        10.2.1 Overview
        10.2.2 Historical and Current Market Trends (2018-2023)
        10.2.3 Market Breakup by Source
        10.2.4 Market Breakup by Product
        10.2.5 Market Breakup by Disease
        10.2.6 Market Breakup by Manufacturing
        10.2.7 Key Players
        10.2.8 Market Forecast (​2024-2032)
    10.3    Honam (Southwestern Region)
        10.3.1 Overview
        10.3.2 Historical and Current Market Trends (2018-2023)
        10.3.3 Market Breakup by Source
        10.3.4 Market Breakup by Product
        10.3.5 Market Breakup by Disease
        10.3.6 Market Breakup by Manufacturing
        10.3.7 Key Players
        10.3.8 Market Forecast (​2024-2032)
    10.4    Hoseo (Central Region)
        10.4.1 Overview
        10.4.2 Historical and Current Market Trends (2018-2023)
        10.4.3 Market Breakup by Source
        10.4.4 Market Breakup by Product
        10.4.5 Market Breakup by Disease
        10.4.6 Market Breakup by Manufacturing
        10.4.7 Key Players
        10.4.8 Market Forecast (​2024-2032)
    10.5    Others
        10.5.1 Historical and Current Market Trends (2018-2023)
        10.5.2 Market Forecast (​2024-2032)
11  South Korea Biologics Market – Competitive Landscape
    11.1    Overview
    11.2    Market Structure
    11.3    Market Player Positioning
    11.4    Top Winning Strategies
    11.5    Competitive Dashboard
    11.6    Company Evaluation Quadrant
12  Profiles of Key Players
    12.1    Company A 
        12.1.1 Business Overview
        12.1.2 Product Portfolio
        12.1.3 Business Strategies
        12.1.4 SWOT Analysis
        12.1.5 Major News and Events
    12.2    Company B
        12.2.1 Business Overview
        12.2.2 Product Portfolio
        12.2.3 Business Strategies
        12.2.4 SWOT Analysis
        12.2.5 Major News and Events
    12.3    Company C
        12.3.1 Business Overview
        12.3.2 Product Portfolio
        12.3.3 Business Strategies
        12.3.4 SWOT Analysis
        12.3.5 Major News and Events
    12.4    Company D 
        12.4.1 Business Overview
        12.4.2 Product Portfolio
        12.4.3 Business Strategies
        12.4.4 SWOT Analysis
        12.4.5 Major News and Events
    12.5    Company E
        12.5.1 Business Overview
        12.5.2 Product Portfolio
        12.5.3 Business Strategies
        12.5.4 SWOT Analysis
        12.5.5 Major News and Events    
    
Company names have not been provided here as this is a sample TOC. The complete list is provided in the report.

13  South Korea Biologics Market - Industry Analysis
    13.1    Drivers, Restraints, and Opportunities
        13.1.1 Overview
        13.1.2 Drivers
        13.1.3 Restraints
        13.1.4 Opportunities
    13.2   Porters Five Forces Analysis
        13.2.1 Overview
        13.2.2 Bargaining Power of Buyers
        13.2.3 Bargaining Power of Suppliers
        13.2.4 Degree of Competition
        13.2.5 Threat of New Entrants
        13.2.6 Threat of Substitutes
    13.3    Value Chain Analysis
14  Appendix

South Korea Biologics Market Report by Source (Microbial, Mammalian, and Others), Product (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi and Molecular Therapy, and Others), Disease (Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, and Others), Manufacturing (Outsourced, In-House), and Region 2024-2032
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials